Date:1/31/2013

es, Volume (Units) by Segment, Historic, 2004-2011 43Figure 17: Cataract Surgery Devices, United States, Volume (Units) by Segment, Forecast, 2011-2018 44Figure 18: Ophthalmic Viscoelastic Devices (OVD), United States, Volume (Units) by Sub-Segment, Historic, 2004-2011 45Figure 19: Ophthalmic Viscoelastic Devices (OVD), United States, Volume (Units) by Sub-Segment, Forecast, 2011-2018 46Figure 20: Cataract Surgery Devices, United States, Company Share (%), 2011 49Figure 21: Glaucoma Surgery Devices, Market Segmentation 50Figure 22: Glaucoma Surgery Devices Market, United States, Revenue Mix ($m), 2011 51Figure 23: Glaucoma Surgery Devices Market, United States, Segment Contribution (%), 2011 52Figure 24: Glaucoma Surgery Devices, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 53Figure 25: Glaucoma Surgery Devices, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 55Figure 26: Glaucoma Surgery Devices, United States, Volume (Units) by Segment, Historic, 2004-2011 57Figure 27: Glaucoma Surgery Devices, United States, Volume (Units) by Segment, Forecast, 2011-2018 58Figure 28: Glaucoma Surgery Devices, United States, Company Share (%), 2011 60Figure 29: Intraocular Lens (IOL), Market Segmentation 62Figure 30: Intraocular Lens (IOL) Market, United States, Revenue Mix ($m), 2011 63Figure 31: Intraocular Lens (IOL) Market, United States, Segment Contribution (%), 2011 64Figure 32: Intraocular Lens (IOL), United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011 65Figure 33: Intraocular Lens (IOL), United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018 67Figure 34: Foldable IOL, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011 69Figure 35: Foldable IOL, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018 71Figure 36: Intraocular Lens (IOL), United States, Volume (Units) by Segment, Historic, 2004-2011 73Figure 37: Intraocular Lens (IO
'/>"/>

SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
Related medicine technology :

1. Kevin Johnson Joins United Allergy Services Board Of Directors
2. The Treatment Landscape for Hepatocellular Carcinoma Will Change Dramatically Over the Next Ten Years Due to the Launch of New Therapies in the United States and EU5
3. Oncologists in the United States and Europe Indicate that Novel Chemotherapies Hold the Most Near-Term Promise for Improving Outcomes in Soft Tissue Sarcoma
4. Virtual Ports Receives Patent Approvals in the United States and Japan
5. United States Hospital Supplies Market Outlook to 2018 - Disposable Hospital Supplies, Mobility Aids and Transportation Equipment, Operating Room Equipment, Sterilization and Disinfectant Equipment and Others
6. Neurocrine Biosciences Announces Additional European And United States Patents Issued On Proprietary VMAT2 Inhibitor
7. Diet Doc Weight Loss Diets and Fast Weight Loss Plans To Seek Patent Protection for the Most Clinically Advanced Diet Offered in the United States.
8. Americans United for Life Celebrates Win for Illinois Conscience Rights in Case AUL Championed Since 2005
9. UCLA Performs First Breathing Lung Transplant In United States
10. United States Oncology Drug Delivery Preferences and Opportunities in Cancer Drug Delivery
11. International Liver Research Community United Behind World Gastroenterology Organisation Action